<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0009563'>Dyskeratosis</z:mp> congenita (DC) is a very rare inherited disorder characterized by skin <z:hpo ids='HP_0001000'>pigmentation</z:hpo>, <z:hpo ids='HP_0008404'>nail dystrophy</z:hpo>, and mucosal <z:e sem="disease" ids="C0023531" disease_type="Neoplastic Process" abbrv="">leukoplakia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>It is also associated with a variety of noncutaneous abnormalities, such as fatal pulmonary complications, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, and <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We report the case of a 32-year-old man with DC associated with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) </plain></SENT>
<SENT sid="3" pm="."><plain>The traditional treatment of DC-associated SAA is allogeneic hematopoietic stem cell transplantation (HSCT) </plain></SENT>
<SENT sid="4" pm="."><plain>However, in this case, an HLA-matched donor was not available </plain></SENT>
<SENT sid="5" pm="."><plain>Therefore our patient was given intensive immunosuppressive therapy with antilymphocyte globulin (ALG) and <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> A (CsA) </plain></SENT>
<SENT sid="6" pm="."><plain>The hemogram findings improved after the treatment, but the patient died of pulmonary complications after being in stable condition for 6 months </plain></SENT>
<SENT sid="7" pm="."><plain>The results support the possible use of intensive immunosuppression with ALG and CsA for DC-associated SAA as an alternative treatment for patients who are not eligible for HSCT </plain></SENT>
</text></document>